Table 1 Treatment efficacy and survival of patients.
Patient | Disease status before transplantation | Efficacy 2 months after CAR-T cells | Efficacy 5 months after CAR-T cells | Time to disease progression | Current efficacy | Survival state | Time of death/follow up duration | Cause of death |
|---|---|---|---|---|---|---|---|---|
1 | PD | PD | Â | Â | Â | Death | 149 d | Disease progression |
2 | PD | PR | PD | Â | Â | Death | 220 d | Disease progression |
3 | SD | CR | Â | 134 d after transplantation | Â | Death | 171 d | Disease progression |
4 | PR | CR | CR | Â | Â | Death | 294 d | Infection |
5 | PR | PR | CR | Â | CR | Survival | 247 d | Â |
6 | PR | PR | CR | Â | CR | Survival | 242 d | Â |
7 | PR | PR | CR | Â | CR | Survival | 162 d | Â |
8 | PR | PR | CR | Â | CR | Survival | 156 d | Â |
